Search Results - Daniel Rayson

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Seronegative Paraneoplastic Opsoclonus–Myoclonus–Ataxia Syndrome Secondary to Low Volume Endocrine-Sensitive Malignancy of Likely Breast Origin by Geraint Berger, Caitlin Jackson-Tarlton, Daniel Rayson, Alexander Silver, Mark Walsh, Ashley Drohan

    Published in Current Oncology (2025-08-01)
    Get full text
    Article


  2. 2

    Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center by John Loggie, Penelope J. Barnes, Michael D. Carter, Daniel Rayson, Gillian C. Bethune

    Published in Breast (2024-06-01)
    Get full text
    Article


  3. 3

    Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective by Jan-Willem Henning, Christine Brezden-Masley, Karen Gelmon, Stephen Chia, Shane Shapera, Micheal McInnis, Daniel Rayson, Jamil Asselah

    Published in Current Oncology (2023-08-01)
    Get full text
    Article


  4. 4

    Impact of the COVID-19 Pandemic on Medical Oncology Workload: A Provincial Review by Margaret Sheridan, Bruce Colwell, Nathan W. D. Lamond, Robyn Macfarlane, Daniel Rayson, Stephanie Snow, Lori A. Wood, Ravi Ramjeesingh

    Published in Current Oncology (2023-03-01)
    Get full text
    Article


  5. 5

    Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

    Published in Current Oncology (2022-12-01)
    Get full text
    Article


  6. 6

    Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Canc... by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

    Published in Current Oncology (2023-05-01)
    Get full text
    Article


Search Tools: